\nCompania Moderna sus\u0163ine c\u0103 vaccinul pe care l-a dezvoltat \u00eempotriva COVID-19 are poten\u0163ial de a asigura o imunitate durabil\u0103 pentru toate grupele de v\u00e2rst\u0103. <\/p>\n
\nConform companiei Moderna, o scrisoare c\u0103tre editorul New England Journal of Medicine a publicat date interimare din Faza 1 a studiului mRNA-1273 condus de Institutul Na\u0163ional de S\u0103n\u0103tate (Na\u0163ional Institute of Health).<\/p>\n
\nAceast\u0103 scrisoare a demonstrat c\u0103 \u00een ziua 119 (la 3 luni dup\u0103 a dou\u0103 doz\u0103 de 100 \u03bcg), anticorpii se reg\u0103sesc la un nivel ridicat \u00een to\u0163i participan\u0163ii la studiu, cu rezultate similare \u00een toate grupurile participante (18-55, 56-70 \u015fi 71+).<\/p>\n
\nModerna preconizeaz\u0103 a avea \u00eentre 100 \u015fi 125 de milioane de doze disponibile la nivel global \u00een primul trimestru al lui 2021 (85-100 de milioane dintre aceste doze disponibile \u00een Statele Unite \u015fi 15-25 de milioane de doze disponibile \u00een afar\u0103 Statelor Unite).<\/p>\n
\nAcest num\u0103r preconizat include cele \u00eentre 500 de milioane \u015fi 1 miliard de doze pe care Modern\u0103 se a\u015fteapt\u0103 s\u0103 le produc\u0103 la nivel global \u00een 2021.<\/p>\n
\n\u201eAceste date interimare sugereaz\u0103 c\u0103 mRNA-1273, vaccinul nostru candidat \u00eempotriva COVID-19, poate genera anticorpi neutralizatori de durat\u0103 \u00een toate grupele de v\u00e2rst\u0103, inclusiv la adul\u0163i v\u00e2rstnici [..] Aceste date ne ofer\u0103 \u015fi mai mult optimism \u015fi speran\u0163a \u00een nivelul \u00eenalt de eficient\u0103 \u00een prevenirea bolii COVID-19, demonstrat de mRNA-1273, va fi unul de durat\u0103”, declar\u0103 Tral Zaks, doctor \u00een medicin\u0103, Chief Medical Officer al Moderna.<\/p>\n","protected":false},"excerpt":{"rendered":"
Compania Moderna sus\u0163ine c\u0103 vaccinul pe care l-a dezvoltat \u00eempotriva COVID-19 are poten\u0163ial de a asigura o imunitate durabil\u0103 pentru toate grupele de v\u00e2rst\u0103. Conform companiei Moderna, o scrisoare c\u0103tre editorul New England Journal of Medicine a publicat date interimare din Faza 1 a studiului mRNA-1273 condus de Institutul Na\u0163ional de S\u0103n\u0103tate (Na\u0163ional Institute of […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[46419,14930],"class_list":["post-188636","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-moderna","tag-vaccin"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/188636","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=188636"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/188636\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=188636"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=188636"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=188636"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}